Pieris Pharma (PIRS) Acquires Non-Exclusive License from Enumeral Biomedical
Tweet Send to a Friend
Pieris Pharma (NASDAQ: PIRS) disclosed that on April 18, 2016, that it and Pieris Pharmaceuticals GmbH, a wholly-owned subsidiary of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
